X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1337) 1337
Book Review (330) 330
Publication (75) 75
Book Chapter (10) 10
Conference Proceeding (4) 4
Magazine Article (4) 4
Book / eBook (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1238) 1238
index medicus (1143) 1143
waldenstrom macroglobulinemia - drug therapy (730) 730
male (614) 614
middle aged (539) 539
female (529) 529
aged (508) 508
hematology (438) 438
oncology (392) 392
rituximab (290) 290
waldenstrom macroglobulinemia - complications (261) 261
adult (258) 258
antineoplastic agents - therapeutic use (226) 226
waldenstrom macroglobulinemia - diagnosis (211) 211
waldenstrom macroglobulinemia - pathology (209) 209
treatment outcome (207) 207
waldenstrom macroglobulinemia (201) 201
antineoplastic combined chemotherapy protocols - therapeutic use (178) 178
aged, 80 and over (165) 165
chronic lymphocytic-leukemia (161) 161
waldenstroms macroglobulinemia (152) 152
abridged index medicus (147) 147
therapy (137) 137
lymphoma (130) 130
prognosis (124) 124
waldenstrom macroglobulinemia - immunology (123) 123
waldenstrom's macroglobulinemia (113) 113
waldenstrom macroglobulinemia - therapy (110) 110
chlorambucil - therapeutic use (108) 108
waldenstrom macroglobulinemia - genetics (107) 107
multiple-myeloma (106) 106
antibodies, monoclonal, murine-derived (105) 105
multiple myeloma - drug therapy (102) 102
macroglobulinemia (98) 98
consensus panel recommendations (97) 97
waldenstrom macroglobulinemia - blood (96) 96
bortezomib (95) 95
antibodies, monoclonal - therapeutic use (94) 94
waldenström macroglobulinemia (94) 94
immunoglobulin m - blood (92) 92
2nd international workshop (88) 88
vidarabine - analogs & derivatives (88) 88
lymphomas (87) 87
cancer (86) 86
multiple myeloma (85) 85
fludarabine (83) 83
cyclophosphamide - therapeutic use (80) 80
animals (77) 77
lymphoplasmacytic lymphoma (73) 73
retrospective studies (73) 73
monoclonal gammopathy (72) 72
phase-ii trial (72) 72
waldenstrom macroglobulinemia - mortality (72) 72
diagnosis, differential (70) 70
drug therapy, combination (70) 70
hematology, oncology and palliative medicine (70) 70
non-hodgkins-lymphoma (70) 70
mutation (69) 69
waldenström's macroglobulinemia (69) 69
chemotherapy (67) 67
cyclophosphamide - administration & dosage (65) 65
follow-up studies (65) 65
medicine, general & internal (65) 65
prednisone - therapeutic use (64) 64
cyclophosphamide (62) 62
disease progression (62) 62
disease-free survival (62) 62
antineoplastic agents - adverse effects (61) 61
leukemia, lymphocytic, chronic, b-cell - drug therapy (61) 61
care and treatment (60) 60
bone marrow - pathology (59) 59
diagnosis (59) 59
vidarabine - therapeutic use (59) 59
survival analysis (58) 58
international workshop (56) 56
survival (56) 56
immunoglobulin m - analysis (55) 55
immunoglobulin m (54) 54
remission induction (53) 53
clinical trials as topic (51) 51
ibrutinib (51) 51
lymphoma, non-hodgkin - drug therapy (51) 51
antineoplastic agents - administration & dosage (50) 50
antineoplastic agents - pharmacology (49) 49
survival rate (49) 49
antineoplastic combined chemotherapy protocols - adverse effects (48) 48
drug therapy (48) 48
leukemia (48) 48
immunoelectrophoresis (47) 47
pyrimidines - therapeutic use (47) 47
recurrence (47) 47
antibodies, monoclonal - administration & dosage (46) 46
myeloid differentiation factor 88 - genetics (46) 46
waldenstrom macroglobulinemia - metabolism (46) 46
pyrazoles - therapeutic use (45) 45
disease (44) 44
drug administration schedule (44) 44
medicine & public health (44) 44
risk factors (43) 43
time factors (43) 43
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1158) 1158
French (54) 54
German (51) 51
Japanese (26) 26
Spanish (15) 15
Italian (12) 12
Chinese (8) 8
Czech (6) 6
Polish (6) 6
Romanian (4) 4
Russian (3) 3
Dutch (2) 2
Swedish (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 15, pp. 1430 - 1440
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 6, pp. 584 - 586
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 25, pp. 2399 - 2410
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 23, pp. 3830 - 3835
Purpose We examined the activity of bortezomib, dexamethasone, and rituximab (BDR) in patients with symptomatic, untreated Waldenstrom macroglobulinemia (WM).... 
CONSENSUS PANEL RECOMMENDATIONS | 2ND INTERNATIONAL WORKSHOP | MANTLE-CELL LYMPHOMA | IN-VITRO | ONCOLOGY | PROTEASOME INHIBITOR BORTEZOMIB | NON-HODGKINS-LYMPHOMA | PHASE-II | RELAPSED MULTIPLE-MYELOMA | CHOP-R | COOPERATIVE-ONCOLOGY-GROUP | Herpes Zoster - prevention & control | Humans | Middle Aged | Pyrazines - administration & dosage | Antibodies, Monoclonal - adverse effects | Hematocrit | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Male | Waldenstrom Macroglobulinemia - pathology | Waldenstrom Macroglobulinemia - drug therapy | Aged, 80 and over | Female | Boronic Acids - administration & dosage | Waldenstrom Macroglobulinemia - blood | Antibodies, Monoclonal, Murine-Derived | Bortezomib | Dexamethasone - administration & dosage | Drug Administration Schedule | Blood Viscosity - drug effects | Kaplan-Meier Estimate | Rituximab | Treatment Outcome | Bone Marrow Neoplasms - secondary | Herpes Zoster - chemically induced | Disease-Free Survival | Immunoglobulin M - blood | Platelet Count | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Aged | Bone Marrow Neoplasms - drug therapy | Index Medicus | Original Reports | Hema15 | Bios3 | Hema23
Journal Article
Cancer, ISSN 0008-543X, 01/2012, Volume 118, Issue 2, pp. 434 - 443
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 19, pp. 3276 - 3282
Journal Article
Journal Article
Journal Article
Journal Article